ARTICLE | Company News
Avid Therapeutics, Emory University deal
October 2, 1995 7:00 AM UTC
The parties executed a previously announced licensing agreement under which Avid receives exclusive worldwide rights to antiviral compounds called polyoxometalates (see BioCentury Nov. 14, 1994). ...